Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. 2004

Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
Department of Women's and Children's Health, University Children's Hospital, SE-751 85 Uppsala, Sweden. britt-marie.frost@kbh.uu.se

The t(12;21) (p13;q22) translocation resulting in ETV6/RUNX1 (previously named TEL/AML1) gene fusion is present in about 25% of children with precursor B-lineage acute lymphoblastic leukemia (B-ALL). We successfully tested 275 precursor B-ALL samples from children aged 1 to 17 years to determine the relation between t(12;21) and in vitro cellular drug resistance, measured by the fluorometric microculture cytotoxicity assay (FMCA). Samples from 83 patients (30%) were positive for t(12;21). The ETV6/RUNX1(+) samples were significantly more sensitive than ETV6/RUNX1(-) samples to doxorubicin, etoposide, amsacrine, and dexamethasone, whereas the opposite was true for cytarabine. After matching for unevenly distributed patient characteristics, that is, excluding patients with high hyperdiploidy (> 51 chromosomes), t(9; 22), t(1;19), or 11q23 rearrangement, the ETV6/RUNX1(+) samples remained significantly more sensitive to doxorubicin (P = .001) and etoposide (P = .001). For the other drugs tested (amsacrine, cytarabine, dexamethasone, prednisolone, vincristine, 6-thioguanine, and 4-hydroperoxy-cyclophosphamide), no significant difference in cellular drug sensitivity was found. In conclusion, we found that the presence of the t(12;21) translocation in childhood precursor B-ALL is associated with a high tumor cell sensitivity to doxorubicin and etoposide. High throughput techniques should now be used to elucidate the cellular mechanisms by which ETV6/RUNX1 gene fusion is linked to increased sensitivity to these drugs.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002881 Chromosomes, Human, Pair 12 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 12
D002891 Chromosomes, Human, Pair 21 A specific pair of GROUP G CHROMOSOMES of the human chromosome classification. Chromosome 21
D004171 Diploidy The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X. Diploid,Diploid Cell,Cell, Diploid,Cells, Diploid,Diploid Cells,Diploidies,Diploids
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins

Related Publications

Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
March 1994, Genes, chromosomes & cancer,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
January 2004, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
July 1996, British journal of haematology,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
March 2006, Haematologica,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
December 1995, Blood,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
July 1998, Japanese journal of cancer research : Gann,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
February 1999, Sangre,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
January 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
August 2000, Blood,
Britt-Marie Frost, and Erik Forestier, and Göran Gustafsson, and Peter Nygren, and Marit Hellebostad, and Olafur G Jonsson, and Jukka Kanerva, and Kjeld Schmiegelow, and Rolf Larsson, and Gudmar Lönnerholm
March 1985, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!